Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (UV,formaldehyde inactivated) Completed Phase 3 Trials for Flu caused by Influenza Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT02242643Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine (GSK2282512A) Compared to FluzoneĀ® Quadrivalent in Children 6 to 35 Months of Age
NCT01440387A Study of Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine FLU-Q-QIV in Adults Aged 18 Years and Older
NCT01218308A Study to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine in Children
NCT01196975A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults
NCT00980005Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children